Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Vertex Pharmaceuticals Inc Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $92.1 Billion
- Q2 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 1,091,299 shares of VRTX stock, worth $530 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
1,091,299
Previous 299,471
264.41%
Holding current value
$530 Million
Previous $125 Million
308.62%
% of portfolio
0.56%
Previous 0.14%
Shares
30 transactions
Others Institutions Holding VRTX
# of Institutions
1,707Shares Held
226MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$13 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.3 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.69 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.15 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $125B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...